Navigation Links
UVa biomedical engineering study shows magnetic field can reduce swelling
Date:1/3/2008

Drug Administration regulates specific claims of medical efficacy, but in general static magnetic fields are viewed as safe," notes Skalak, who has been carefully studying magnets for a number of years in order to develop real scientific evidence about the effectiveness of magnetic therapy.

Skalak's lab leads the field in the area of microcirculation research - the study of blood flow through the body's tiniest blood vessels. With a five-year, $875,000 grant from the National Institutes of Health's National Center for Complementary and Alternative Medicine, Skalak and Morris set out to investigate the effect of magnetic therapy on microcirculation. Initially, they sought to examine a major claim made by companies that sell magnets: that magnets increase blood flow.

In their initial study, magnets of 70 milliTesla (mT) field strength - about 10 times the strength of the common refrigerator variety - were placed near the rats' blood vessels. Quantitative measurements of blood vessel diameter were taken both before and after exposure to the static magnetic fields - the force created by the magnets. Morris and Skalak found that the force had a significant effect: the vessels that had been dilated constricted, and the constricted vessels dilated, implying that the magnetic field could induce vessel relaxation in tissues with constrained blood supply, ultimately increasing blood flow.

Dilation of blood vessels is often a major cause of swelling at sites of trauma to soft tissues such as muscles or ligaments. The prior results on vessel constriction led Morris and Skalak to look closer at whether magnets, by limiting blood flow in such cases, would also reduce swelling.

Given the results of this latest study, Skalak envisions the magnets being particularly useful to high school, college and professional sports teams, as well as school nurses and retirement communities. He has plans to continue testing the effectiveness of magnets through
'/>"/>

Contact: Jeff Hanna
jhanna@virginia.edu
434-243-2070
University of Virginia
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Boston University biomedical engineers find chink in bacterias armor
2. $22 million gift from Alfred Taubman launches new biomedical research institute
3. USC biomedical team to participate in $6 million low vision project
4. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
5. Innovative civil engineering application promises cleaner waters
6. UC-San Diego Engineering Honor Society wins most outstanding chapter award
7. UCSD bioengineering grad student wins leadership award
8. Synaptics SecurePad(TM) Selected as CES Innovations 2008 Design and Engineering Award Honoree
9. Setting a course for the future of tissue engineering
10. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
11. A study by the MUHC and McGill University opens a new door to understanding cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Breakthrough in monitoring tropical deforestation announced in Copenhagen 2Hebrew University, American researchers show 'trigger' to stem cell differentiation 2Pathological gambling may be successfully treated with medications for substance addiction 2ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference 13018 1ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference 13018 2ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference 13018 3Significant Milestone Marks the Beginning of FDA Authorized Breast Cancer Trial 13016 1Significant Milestone Marks the Beginning of FDA Authorized Breast Cancer Trial 13016 2Significant Milestone Marks the Beginning of FDA Authorized Breast Cancer Trial 13016 3Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 1Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 2Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 3Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 4Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 5Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 6Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 7Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 8Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 9Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 10Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 11Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 12Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 13Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 14Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 15Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 16Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 17